PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Research and Development, Inova Diagnostics, San Diego, CA, USA.\', \'Allergy, Clinical Immunology and Rheumatology Unit, Immunorheumatology Research Laboratory, IRCCS Istituto Auxologico Italiano, Milan, Italy.\', \'Immunology and Allergology Laboratory Unit, Rheumatology Unit, S. Giovanni Di Dio Hospital, Florence, Italy.\', \'Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/1744666X.2021.1905526
?:hasPublicationType
?:journal
  • Expert review of clinical immunology
is ?:pmid of
?:pmid
?:pmid
  • 33750254
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.097
?:rankingScore_hIndex
  • 38
is ?:relation_isRelatedTo_publication of
?:title
  • Circulating Calprotectin as a Biomarker of COVID-19 Severity.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33750254>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33750254>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all